Roots Analysis has announced the addition of the (Avastin) Bevacizumab Biosimilars – Pipeline Review and Partnerships” report to its list of offerings.
Biosimilars of bevacizumab are currently approved / being developed to treat colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, and cervical cancer. Considering that several enemy products are already in the market, and several others are under development, the bevacizumab biosimilar market is anticipated to witness noteworthy growth in the foreseen future.
For additional details, please visit
https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html
Key Report Highlights
In 2020, Roche lost more than USD 6 billion in international revenues due to biosimilar competition
This substantial erosion in sales is evidence of the market capturing potential of biosimilars, despite the numerous barriers that exist both in the United States and internationally, which prevent such drugs from challenging their much higher-priced originator products
To request a sample copy / brochure of this report, please visit this
Key Questions Answered
§ Who are the key players engaged in the development of biosimilars of bevacizumab?
§ In which global marketplaces are Avastin® biosimilars currently available?
§ What is the current scenario within the clinical development landscape of bevacizumab biosimilars?
§ How many biosimilar development programs have and what were the reasons?
§ Who are the key players involved in the commercialization of bevacizumab biosimilars across the world?
§ What kind of partnerships have been inked between stakeholders in this domain?
For additional details, please visit
https://www.rootsanalysis.com/reports/avastin-biosimilars-pipeline-review-and-partnerships.html or email [email protected]
You may also be interested in the following titles:
1. HUMIRA® (Adalimumab) Biosimilars – Pipeline Review and Partnerships
2. Herceptin® (Trastuzumab) Biosimilars – Pipeline Review and Partnerships
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
Global Europium Market is anticipated to reach USD 308.9 million by 2025.
Europium is a rare earth metal that is ductile and soft, slivery-white in color, instantly oxidizes in water and air.
Europium is one of the least abundant elements in the world and mostly found in the minerals like monazite and bastnaesite.
Globally, technical growth in the field of earth metal nano-crystals will drive the market growth.The factors that propel the growth of the Europium industry include increasing application scope of the product in the electrical, automobile, material sciences energy, and industries, developing interest from LEDs, and flat panel displays.
On the other hand, there are factors that may hamper the development of the market including strict government regulations, high cost involved in Research and development.
Europium Market is anticipated to grow at a significant CAGR of 4.6% in the upcoming period as the scope, product types, and its applications are increasing across the globe.The market may be explored by application, end user, and geography.
